Biotalys NV Total Liabilities
Biotalys NV total liabilities. Based on the latest financial reports, Biotalys NV (BTLS) has total liabilities worth €9.18 Million EUR (≈ $10.73 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Biotalys NV liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Biotalys NV (2018–2024)
Total liabilities of Biotalys NV from 2018 to 2024. This chart illustrates how Biotalys NV's total liabilities have evolved over time, based on quarterly financial data.
Biotalys NV Competitors by Total Liabilities
The table below lists competitors of Biotalys NV ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Dwarikesh Sugar Industries Limited
NSE:DWARKESH
|
India | Rs4.69 Billion |
|
Peace Acquisition Corp Ordinary Shares
NASDAQ:PECE
|
USA | $132.80K |
|
Heidmar Maritime Holdings Corp. Common Stock
NASDAQ:HMR
|
USA | $82.97 Million |
|
TDM Berhad
KLSE:2054
|
Malaysia | RM1.07 Billion |
|
NH All One REIT Co Ltd
KO:400760
|
Korea | ₩723.86 Billion |
|
Unique Engineering and Construction Public Company Limited
BK:UNIQ
|
Thailand | ฿35.14 Billion |
|
Viet Nam Power Development JSC
VN:VPD
|
Vietnam | ₫361.15 Billion |
|
Rallybio Corp
NASDAQ:RLYB
|
USA | $3.57 Million |
Liability Composition Analysis (2018–2024)
This chart breaks down Biotalys NV's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Biotalys NV total assets.
Liquidity & Leverage Metrics
Biotalys NV Total Liabilities Ratios Explained
Biotalys NV total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.61 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.46 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Biotalys NV's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Biotalys NV (2018–2024)
The table below shows the annual total liabilities of Biotalys NV from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €9.14 Million ≈ $10.69 Million |
-16.99% |
| 2023-12-31 | €11.01 Million ≈ $12.88 Million |
-3.42% |
| 2022-12-31 | €11.40 Million ≈ $13.33 Million |
+0.39% |
| 2021-12-31 | €11.36 Million ≈ $13.28 Million |
+7.02% |
| 2020-12-31 | €10.61 Million ≈ $12.41 Million |
+64.81% |
| 2019-12-31 | €6.44 Million ≈ $7.53 Million |
-25.64% |
| 2018-12-31 | €8.66 Million ≈ $10.12 Million |
-- |
About Biotalys NV
Biotalys NV, an agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also provides the AGROBODY Foundry technology platform, which generates protein-based crop protection products. In addition, the company develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6… Read more